X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

AXSM

Closed

Axsome Therapeutics Inc

102.97
-1.42 (-1.36%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 104.39
Day's Range: 102.46 - 106.34
Send
When Written:
 
61.68
Axsome Therapeutics Inc is a biopharmaceutical company based in New York, USA. The company is focused on developing novel therapies for the treatment of central nervous system (CNS) disorders, including depression, migraine, and Alzheimer's disease.

Axsome's lead product candidate is AXS-05, which is a combination of two drugs - dextromethorphan and bupropion. The drug is being developed for the treatment of major depressive disorder (MDD) and treatment-resistant depression (TRD).

The company also has other product candidates in its pipeline, including AXS-07 for the treatment of migraine and AXS-12 for the treatment of narcolepsy.

Axsome Therapeutics was founded in 2012 and went public in 2015. The company has partnerships with various academic institutions and research organizations, including Duke University, Massachusetts General Hospital, and the National Institute of Mental Health.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X